Vera Therapeutics Inc

VERANASDAQ · USD
34.00USD0.00 (-0.79%)
1310

Vera Therapeutics Inc (VERA) Option Chain

As of September 18, 2026, Vera Therapeutics Inc is trading at $34.00, a -0.79% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 60.7%. IV Rank is 4%.

Read more

Tracking the VERA option chain helps you see every strike and expiry on Vera Therapeutics Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Vera Therapeutics Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of VERA options activity at a glance. Use our scanner to monitor the VERA option chain in real time and filter for the VERA options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For VERA stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the VERA option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where VERA stock options are being actively traded and where they are not.

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. It is also developing MAU868, a monoclonal antibody for the treatment of BK viremia infections and is under Phase 2 clinical trial. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc.

in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Vera Therapeutics Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen VERA options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of VERA stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile11.51% Subdued
  • Market cap (M$)2,450
  • 52 weeks high-39.34%
  • 52 weeks low47.51%
  • Analyst recommendationStrong Buy
    1.14
  • Target price$77.50
    127.94% above the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-11-04
  • P/E
  • Future P/E
  • EPS (ttm)-5.87
  • EPS growth next 5 years53.56%

As of September 18, 2026

2026-10-16
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
3.672072000.809.008.4011.2025.00-26.470.350.000.355012296.33
24.513101.354.003.707.0030.00-11.760.451.050.000.753218075.49
59.4896792.030.001.552.5035.00+2.942.453.301.001.881712440.52
85.217762020.500.000.400.6040.00+17.654.707.506.000.1001014.79
96.0516700.250.000.050.4545.00+32.359.8012.3011.000.05013.95

As of September 18, 2026

Scan the full option chain in one place

Browse the full VERA option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial